Hi, what are you looking for?
Teva CFO Eyal Desheh: We appreciate the strong support we received which stems from the compelling economics of this transaction
The deal, the largest ever acquisition by an Israeli company, is in cash and shares.
Teva will pay over $45 billion for the botox maker unit, report the "Wall Street Journal."
Allergan's David Pyott had to fight Bill Ackman Day and Night to avoid a takeover by Valeant.
– Hedge fund mogul William Ackman told investors they could see a $6 billion payday when he closes the chapter on Allergan Inc.,...
The seven-month battle over American Botox haven pharmaceutical company Allergan is over, after it accepted a friendly takeover bid from Irish integrated specialty pharmaceutical...
After an intense and acrimonious months long battle for a hostile takeover of Allergan, Bill Ackman, who owns a 9.7% stake in the company,...
– Activist investor William “Bill” Ackman said on Tuesday he supports the $66 billion deal in which Actavis PLC will buy Allergan Inc and...
– Botox maker Allergan Inc on Monday accepted a $66 billion takeover bid from Actavis Plc, ending a seven-month hostile pursuit by activist investor...
Salix Pharmaceuticals was considered as a potential buy by Allergan to ward off a hostile takeover by Valeant Pharmaceuticals and activist investor Bill Ackman....